Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Erik Friedrich
Institution:
Merck Healthcare KGaA, Darmstadt (Germany)
Observed institution:
Merck Healthcare KGaA, Darmstadt (Germany)
ORCID:
0000-0003-0173-1190
Observed ORCID:
0000-0003-0173-1190
OpenAlex ID:
A5038767563
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686
2024
·
Timo Heinrich
, Daniel Schwarz
, et al.
·
Journal of Medicinal Chemistry
·
12
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors
2025
·
Timo Heinrich
, Alessia Gambardella
, et al.
·
Journal of Medicinal Chemistry
·
8
Synthesis and crystal structure of rac-2-(1,3-dioxoisoindolin-2-yl)ethyl 4-methyl-N-phenyl-N′-(triisopropylsilyl)benzenesulfondiimidoate: the first member of a new substance class
2022
·
Erik Friedrich
, Timo Heinrich
, et al.
·
Acta Crystallographica Section E Crystallographic Communications
·
4
PDF
Show more works
View as search
Works count:
3
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type